Cipla | CIPLA - Nettoeinkommen

Aktienkurs
1,277.30
Täglich Wechseln
-4.60 -0.36%
Monatlich
-3.88%
Jährlich
-14.80%
Q1 Prognose
1,289.06




Nettoeinkommen Veränderung Datum
Arca Biopharma USD -21M 4.78M 2025-03
aTyr Pharma USD -25.74M 6.21M 2025-09
Bio Path USD -2.85M 99K 2025-03
Brainstorm Cell Therapeutics USD -2.86M 109K 2025-03
Capricor Therapeutics USD -24.39M 17.27M 2025-03
Cara Therapeutics USD -4.91M 2.77M 2025-03
Cipla INR 6.76B 6.75B 2025-12
Dr.Reddys Laboratories INR 12.1B 2.27B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Immunic USD -24.37M 2.99M 2024-09
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sun Pharmaceuticals INR 33.69B 2.51B 2025-12
TherapeuticsMD USD -1.09M 356K 2024-06
UPL INR 3.96B 1.57B 2025-12